Editing OBGYN - Gyn Cancers
From Iusmicm
Warning: You are not logged in.
Your IP address will be recorded in this page's edit history.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Current revision | Your text | ||
Line 10: | Line 10: | ||
**vagina | **vagina | ||
**trophoblastic | **trophoblastic | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
==Epidemiology== | ==Epidemiology== | ||
Line 262: | Line 235: | ||
*Male breast cancer is so rare that if seen, suspect brca(2) mutation. | *Male breast cancer is so rare that if seen, suspect brca(2) mutation. | ||
- | ===Clinical Use of Serum CA 125 | + | ===Clinical Use of Serum CA 125= |
*CA 125 can be used to '''following response to chemotherapy''' | *CA 125 can be used to '''following response to chemotherapy''' | ||
*CA 125 can be used for '''surveillance for patients with known genetic mutation or strong family history''' indicative of a hereditary inheritance pattern | *CA 125 can be used for '''surveillance for patients with known genetic mutation or strong family history''' indicative of a hereditary inheritance pattern | ||
Line 549: | Line 522: | ||
**Stage 4: 3%; <10% | **Stage 4: 3%; <10% | ||
- | === | + | ==Uterine Cancer== |
+ | |||
+ | ===Uterine Cancer: Diagnosis=== | ||
*Pts with uterine cancer often present with AUB / PMB: | *Pts with uterine cancer often present with AUB / PMB: | ||
**Abnormal Uterine Bleeding | **Abnormal Uterine Bleeding | ||
Line 559: | Line 534: | ||
*Hysteroscopy | *Hysteroscopy | ||
- | === | + | ===Uterine Cancer: Treatment=== |
*Mainstay is surgical | *Mainstay is surgical | ||
**Total hysterectomy | **Total hysterectomy | ||
Line 565: | Line 540: | ||
**Pelvic & PA Nodes | **Pelvic & PA Nodes | ||
- | === | + | ===Uterine Cancer: Surgical Staging=== |
*Conceptual rationale: | *Conceptual rationale: | ||
**Defines extent of disease | **Defines extent of disease | ||
Line 573: | Line 548: | ||
**Allows comparison of therapeutic results | **Allows comparison of therapeutic results | ||
- | === | + | ===Uterine Cancer: Adjuvant Therapy=== |
*Options: | *Options: | ||
**Brachytherapy | **Brachytherapy |